Simmons Remains Sidelined on Core Laboratories (CLB) - PT to $115
Get Alerts CLB Hot Sheet
Rating Summary:
9 Buy, 12 Hold, 8 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 13
Join SI Premium – FREE
Simmons maintained a Neutral rating on Core Laboratories (NYSE: CLB), and raised the price target to $115.00 (from $105.00), following the company's 1Q earnings review.
Analyst Bill Herbert commented, "Respectable quarter given oppressive conditions. While CLB's value proposition provides the company above average revenue and margin insulation, it is far from immune from the Darwinian realities confronting the industry. Q2 guidance was plausibly in-line with Street expectations. FCF generation was robust and should continue to be the fulcrum of the story - needs to be in order for CLB to adhere to its 2.5x net debt/adjusted EBITDA covenant (currently 1.9x) given the downward trajectory in trailing EBITDA and the need to continue paying down debt. Stock is fairly/fully valued, trading at 30x our estimate of 2018 EPS. We ascribe a high 20sx P/E as a targeted multiple based on the company's leadership standing within the higher realms of oil technology and value proposition to resource holders, as well as best-in-class ROCE."
For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.
Shares of Core Laboratories closed at $124.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baidu (BIDU) PT Lowered to $145 at HSBC
- Enphase Energy (ENPH) PT Lowered to $113 at BMO Capital
- RTX Corp. (RTX) PT Raised to $119 at Susquehanna
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!